Key Finding
A triple-blind RCT protocol is underway testing whether patient-controlled transcutaneous electrical acupoint stimulation, used at home on demand, can meaningfully reduce cancer-induced bone pain in non-small cell lung cancer patients already receiving opioid therapy.
Living with bone pain caused by cancer is one of the most challenging aspects of a lung cancer diagnosis. Opioid medications help, but they come with side effects and don't always provide complete relief. Researchers in China are now testing whether a wearable, patient-controlled acupuncture device could offer additional pain relief at home — on your own schedule.
The treatment is called Transcutaneous Electrical Acupoint Stimulation, or TEAS. Instead of needles, it uses small adhesive patches placed on acupuncture points that deliver gentle electrical pulses through the skin. The "patient-controlled" aspect means users can activate the device themselves whenever they feel pain, much like a patient-controlled pain pump in a hospital — but designed for home use.
This study is enrolling 188 people with non-small cell lung cancer (NSCLC) who have bone metastases and are already taking strong opioid pain medications. Participants are randomly assigned to either a real TEAS device or a sham device using non-conductive patches that look identical. Neither participants nor assessors know which device is real, making this one of the more rigorously designed acupuncture trials to date.
The trial runs for 12 weeks, with four treatment courses of seven days each. Researchers are measuring pain levels, quality of life, mood, and blood counts at regular intervals. The main question they want to answer: does real TEAS meaningfully reduce average pain scores after four weeks compared to the sham device?
While results are not yet available — this is a study protocol describing the design — the approach is exciting because it brings acupuncture-based therapy into the home, making it accessible even for patients too ill to travel to a clinic.
If you or a loved one is managing cancer-related pain, speak with a licensed acupuncturist or integrative oncology specialist to explore whether electroacupuncture or TEAS may be appropriate alongside your current treatment plan.
This registered RCT (NCT05730972) evaluates patient-controlled Transcutaneous Electrical Acupoint Stimulation (PC-TEAS) as an adjunct analgesic intervention for cancer-induced bone pain (CIBP) in non-small cell lung cancer (NSCLC) patients with bone metastases maintained on potent opioid analgesics. The prospective, triple-blind, sham-controlled design addresses a longstanding methodological challenge in acupuncture research by utilizing non-conductive gel patches as an indistinguishable sham comparator. A target sample of 188 participants across four Chinese medical centers will be randomized 1:1 to true or sham PC-TEAS over four 7-day courses (12 weeks total). The primary endpoint is BPI average pain response rate at week 4. Secondary outcomes include additional pain indices, QoL, psychological measures, and routine hematology. The patient-controlled, home-based delivery model is clinically significant, potentially improving treatment adherence and accessibility for debilitated patients. Practitioners should monitor publication of results as this protocol represents a methodologically rigorous framework for evaluating electroacupuncture modalities in integrative oncology pain management.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Electroacupuncture produced a statistically significant reduction in BMI of 1.50 points greater than sham treatment at 12 weeks in women with obese PCOS, with benefits to BMI and quality of life sustained through 24 weeks post-intervention.
📌 Electroacupuncture at ST36, ST37, and PC6 significantly accelerated the return of gastrointestinal function — including time to first flatus, defecation, oral fluid intake, and ambulation — and reduced pain scores at 72 hours in patients recovering from laparoscopic radical gastrectomy.
📌 In a Bayesian network meta-analysis of 783 patients, suspension training, Pilates, and combined abdominal support with core stability exercise ranked highest for reducing inter-rectus distance above, at, and below the umbilicus respectively, while electroacupuncture was recognized as one of 11 viable rehabilitation therapies for diastasis recti abdominis.